Synthetic vascular smooth muscle cells (VSMCs) play important roles in atherosclerosis, in-stent restenosis, and transplant vasculopathy. We investigated the synthetic activity of VSMCs in the atherosclerotic carotid artery using 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET). Atherosclerosis was induced in rats by partial ligation of the right carotid artery coupled with an atherogenic diet and vitamin D injections (2 consecutive days, 600,000 IU/day). One month later, rats were imaged by F-18 FDG PET. The atherosclerotic right carotid arteries showed prominent luminal narrowing with neointimal hyperplasia. The regions with neointimal hyperplasia were composed of α-smooth muscle actin-positive cells with decreased expression of smooth muscle myosin heavy chain. Surrogate markers of synthetic VSMCs such as collagen type III, cyclophilin A, and matrix metallopeptidase-9 were increased in neointima region. However, neither macrophages nor neutrophils were observed in regions with neointimal hyperplasia. F-18 FDG PET imaging and autoradiography showed elevated FDG uptake into the atherosclerotic carotid artery. The inner vessel layer showed higher tracer uptake than the outer layer. Consistently, the expression of glucose transporter 1 was highly increased in neointima. The present results indicate that F-18 FDG PET may be a useful tool for evaluating synthetic activities of VSMCs in vascular remodeling disorders.
Vascular smooth muscle cells (VSMCs) play important roles in the pathophysiological processes of various vascular disorders, such as atherosclerosis, in-stent restenosis, and transplant vasculopathy1. Based on their functions such as contraction, migration, or pro-inflammation, VSMCs can be subdivided into contractile or synthetic phenotypes2, 3. In the normal state, the majority of VSMCs in blood vessels exhibit the contractile phenotype as opposed to the synthetic phenotype2, 3. However, in vascular injury or in the inflammatory state, VSMCs switch from the contractile to the synthetic phenotype2, 3. Synthetic VSMCs migrate to the intima and form neointimal hyperplasia with inflammatory characteristics2, 3. Thus, targeting synthetic VSMCs is an attractive therapeutic strategy for treating vascular remodeling disorders1.
Several molecular imaging studies have reported significant increases of VSMC and macrophage populations in neointimal regions in patients with atherosclerosis4, 5 and in a rabbit model of atherosclerosis6. However, none of these studies examined VSMC phenotype. Pyla et al.7 reported that synthetic VSMCs exhibit high expression of facilitative glucose transporters (GLUTs), including GLUT1, a well-known FDG transporter8. Thus, measurement of glucose uptake may be a useful tool for distinguishing synthetic from contractile VSMCs.
Partial carotid artery ligation is a well-established technique for generating an animal model of atherosclerosis9. Wei et al.10 reported that the neointima in rats subjected to partial carotid artery ligation exhibited a high population of VSMCs. 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) is an established noninvasive image modality for measuring vascular glucose consumption4. In the present study, therefore, we investigated synthetic VSMC activities using F-18 FDG PET in an atherosclerotic rat model of partial carotid artery ligation.
The atherosclerotic right carotid arteries presented prominent luminal narrowing with neointimal hyperplasia, while the normal carotid arteries showed no neointimal hyperplasia (Fig. 1A and B). The maximal intimal thickness of atherosclerotic arteries and normal arteries were 137.72 ± 54.46 (mean ± SD; standard deviation) µm and 8.04 ± 0.87 (mean ± SD) µm, respectively (p = 0.021, Fig. 1C). The maximal media thickness of atherosclerotic arteries and normal arteries were 39.2 ± 5.63 (mean ± SD) µm and 35.86 ± 5.74 (mean ± SD) µm, respectively (p = 0.49, Fig. 1C).
Normal artery was composed of smooth muscle myosin heavy chain (SM-MHC) and α-smooth muscle actin (α-SMA)-positive VSMCs in media (Fig. 2). The neointima in atherosclerotic right carotid artery exhibited many α-SMA-positive VSMCs, whereas SM-MHC-positive VSMCs, CD68-positive macrophages or myeloperoxidase (MPO)-positive neutrophils were scantly observed (Fig. 3). The neointimas exhibited significant collagen type III deposition (Fig. 4), which has been shown to be mainly excreted by synthetic VSMCs11. Furthermore, the thickened neointima showed increased expression of cyclophilin A and matrix metallopeptidase-9 (MMP-9) (Fig. 4), both of which are established hallmarks of synthetic VSMC activity12, 13.
F-18 FDG PET
Increased FDG uptake was observed along the atherosclerotic (right) carotid artery (Fig. 5A and B). The corresponding maximum SUV was 3.28 ± 0.43 (mean ± SD). As shown in the transverse view in Fig. 5B-a, the inner circular layer of the right carotid artery showed higher tracer uptake than the outer layer. In the normal control group, no FDG uptake was apparent in either the right or left carotid artery (Fig. 5A and B). The corresponding maximum SUV was 0.86 ± 0.1 (mean ± SD). Atherosclerotic carotid artery showed significantly higher maximum SUV than the normal control group (p = 0.029, Fig. 5C).
Autoradiography and glucose transporter 1 (GLUT1)
Consistent with the in vivo PET imaging, autoradiography showed much higher radioactivity in the right carotid artery than in the left carotid artery (Fig. 6A). Furthermore, higher radioactivity was observed in the inner layer compared to the outer layer. Western blotting showed increased GLUT1 expression in atherosclerotic right carotid artery (Fig. 6B). Immunohistochemistry further demonstrated that GLUT1 expression was increased by synthetic VSMCs in neointimal region of atherosclerotic right carotid artery (Fig. 6C).
In the atherosclerotic rat model used in the present study, the neointima became hypertrophic and exhibited a large VSMC population. However, few inflammatory cells such as macrophages or neutrophils were observed. Our findings are similar to those previously found in a high fat diet-induced atherosclerotic rat model10. Using F-18 FDG PET, we found that VSMCs from the neointima exhibited the synthetic phenotype rather than the contractile phenotype.
When blood vessels are damaged, VSMCs can switch from the contractile to the synthetic phenotype2, 3. During the process of neointimal hyperplasia, SM-MHC which is a well-known marker of contractile VSMC is decreased in neointima whereas α-SMA expression is preserved 14,15,16. Our results are consistent with these previous studies. In the present study, we further found that surrogate markers of synthetic VSMCs such as collagen type III, cyclophilin A, and MMP-9 were increased in the neointima. Therefore, synthetic VSMCs appear to constitute the majority of the neonitmal hyperplasia region.
In general, glucose uptake is retained in normal VSMCs17 and is increased by inflammatory stimuli18. As expected, F-18 FDG PET imaging and autoradiography revealed prominent uptake of FDG in the right carotid artery of atherosclerotic rats. However, FDG uptake was not observed in the right carotid artery of normal rats. Interestingly, FDG distribution appeared to be stratified in the atherosclerotic right carotid artery, with higher FDG uptake in the inner circular layer compared to the surrounding outer layer. These findings were further supported by the increased expression of GLUT1 in synthetic VSMCs of neointima region. Although further studies are warranted to clarify the mechanisms underlying this stratified distribution, we hypothesize that the synthetic activity of VSMCs may be greater in the early phase of neointimal hyperplasia than in the later phases.
F-18 FDG PET is a potentially useful tool for evaluating the activity of synthetic VSMCs in a wide range of vascular remodeling diseases. In atherosclerosis, synthetic VSMCs induce neointimal hyperplasia, narrow the lumen, and provide substrates for lipoprotein retention, thereby accelerating the progression of atherosclerosis19. In addition to synthetic VSMCs, inflammatory responses also play a key role in vascular wall damage in atherosclerosis20. In particular, macrophages appear to significantly contribute to foam cell formation and plaque rupture20. While neointimal hyperplasia is also formed in in-stent restenosis and transplant vasculopathy, inflammatory responses appear to play only a minor role in these vasculopathies19. Recently, Kim et al.21 reported that 68Ga-labeled NOTA-neomannosylated human serum albumin (MSA) could target macrophages in atherosclerosis. Using a combination of FDG and MSA, the molecular basis of synthetic VSMC and macrophage activities in atherosclerotic lesions could be easily obtained.
The activity of synthetic VSMCs was successfully visualized by F-18 FDG PET. Therefore, F-18 FDG PET is a promising noninvasive imaging modality for evaluating synthetic VSMCs, especially in vascular remodeling disorders.
Materials and Methods
Eight male Sprague-Dawley (SD) rats (7 weeks old, 200 g body weight) were purchased from Orient-Bio (Seongnam, Korea). 4 rats were enrolled in atherosclerotic group and 4 rats were in normal control group. All rats were maintained under a 12-h/12-h day/night cycle with ad libitum water and meals. All experimental protocols and procedures were approved by the Ethics Committee and the Institutional Animal Care and Use Committee of Korea University College of Medicine (Approval No. KOREA-2016-0041). All experiments were performed in accordance with the approved guidelines and regulations.
Induction of atherosclerosis
After a 1-week adaptation period, right partial carotid artery ligation was performed as previously described9. Briefly, anesthesia was induced with 3.5% isoflurane with a 2:1 N2O/O2 mixture in a vented anesthesia chamber and then maintained by the administration of 2 to 2.5% isoflurane with a 2:1 N2O/O2 mixture through a nasal cone. The right external carotid artery, right internal carotid artery, and right occipital artery were ligated with a 6-0 silk suture. After ligation, vitamin D3 (6 × 105 IU/kg) was intraperitoneally injected for 2 consecutive days22, with the exception of the normal control group. Rebsamen et al.23 reported that vitamin D3 facilitates VSMC migration in the SD rat aorta. The atherosclerotic group was fed daily with a commercially available atherogenic diet (D12336, Research Diets, NJ, USA) for 4 weeks. The normal group underwent a sham operation without ligation of carotid arteries or vitamin D3 injections. Normal rats were fed a diet of normal chow for 4 weeks.
18F-FDG PET imaging and analysis
Images were acquired using a small animal PET/CT (computed tomography) scanner (eXplore Vista DR PET/CT, GE Healthcare, Milwaukee, WI, USA). Rats were not fasted before examination and were anesthetized with 2% isoflurane at 1 L/min oxygen flow during the PET/CT scan. Rats were placed in the prone position under the scanner. PET image acquisition started 40 min after the injection of 37 MBq/0.2 ml of F-18 FDG via the tail vein. Static PET scans were acquired for 20 min in a single bed position covering the carotid artery region. The axial field of view (FOV) of the PET scanner was 48 mm in length. CT scanning (40 kV, 250 µA) was initiated after PET scanning of the same area. Images were reconstructed using Fourier rebinning and the ordered subsets expectation maximization (OSEM) algorithm with decay, attenuation, random, and normalization corrections. The voxel size was 0.3875 × 0.3875 mm; axial slice thickness was 0.775 mm. Maximum intensity projection (MIP) images, axial views, sagittal views, and fusion images were processed after reconstruction. Following image reconstruction, image analysis was performed with A Medical Image Data Examiner Software (AMIDE, version 1.0.4)24. On each image, regions of interest (ROI) were drawn over the carotid artery region and the standardized uptake values (SUVs) were measured. The SUV was calculated as activity concentration (ROI; MBq/ml)/injected dose (MBq)/total body weight (g).
Immediately after completion of PET/CT scanning, the carotid arteries were harvested, fixed in 4% paraformaldehyde (PFA), and mounted on glass slides. The prepared tissues were exposed to imaging plates and images were acquired using a BAS-200 system (FLA-2000, FUJIFILM, Tokyo, Japan).
Harvested carotid arteries were fixed with 4% PFA and preserved in 30% sucrose solution. Tissues were embedded in Optimal Cutting Temperature (OCT) compound (Scigen Scientific, Gardena, CA, USA). Axial sections of 4-μm thickness were cut using a cryostat microtome (Leica CM 3050 S, Leica Microsystems, Wetzlar, Germany). The molecular profiles of the carotid artery lesions were investigated by immunofluorescence. To this end, sections were blocked in 5% goat serum in phosphate-buffered saline (PBS) with 0.1% Triton X-100 for 60 min and incubated at 4 °C with the following antibodies: anti-α-SMA (1:200 dilution, ab7817 or ab5694, Abcam, Cambridge, MA, USA), anti-SM-MHC (1:200 dilution, ab683, Abcam, Cambridge, MA, USA), anti-CD68 (1:200 dilution, MCA341R, Serotec, Oxford, UK), anti-myeloperoxidase (1:800 dilution, A0398, DAKO, Glostrup, Denmark), anti-cyclophilin A (1:100 dilution, ab41684, Abcam, Cambridgem MA, USA), anti-MMP-9 (1:200 dilution, AB19016, Merck Millipore, Billerica, MA, USA), anti-collagen type III (1:200 dilution, ab7778, Abcam, Cambridge, MA, USA), and anti-GLUT1 (1:200 dilution, ab652, Abcam, Cambridge, MA, USA). Alexa Fluor 555-conjugated goat anti-mouse IgG (1:400 dilution, A21424, Invitrogen, Carlsbad, CA, USA) and Alexa Fluor 488-conjugated goat anti-rabbit IgG (1:400 dilution, A11034, Invitrogen, Carlsbad, CA, USA) were used as secondary antibodies. Cell nuclei were counterstained with DAPI. Histopathologic evaluation was performed by staining with hematoxylin and eosin. All images were acquired on a confocal microscope (LSM800, Carl Zeiss, Oberkochen, Germany) or an upright light microscope (BX51, Olympus, Tokyo, Japan).
Harvested carotid arteries were homogenized in RIPA buffer (GeneDepot, Barker, TX, USA) and centrifuged at 13,000 rpm for 15 min at 4 °C. The protein concentration of supernatant was determined using bicinchoninic acid reagent (Thermo Fisher, Waltham, MA, USA). Proteins were separated using an 8% sodium dodecyl sulfate polyacrylamide gel electrophoresis gel and transferred to a polyvinyldine fluoride membrane (PVDF, Merck Millipore, Billerica, MA, USA). The membranes were blocked for 1 h with 5% skim milk in TBS-T (20 mM Tris-HCl (pH 7.6) containing 0.8% NaCl and 0.1% Tween 20). Then, the membranes were incubated with antibodies against GLUT1 (1:500 dilution, ab15309, Abcam, Cambridge, MA, USA) and glyceraldehyde 3-phosphate dehydrogenase (GAPDH) (1:2000 dilution, MAB374, Merck Millipore, Billerica, MA, USA). After washing with TBS-T, it was incubated with goat anti-rabbit or anti-mouse horseradish peroxidase conjugated secondary antibodies (1:30000 dilution, A16110 or 31430, Thermo Fisher, Waltham, MA, USA). To obtain protein bands, PVDF membranes were detected with X-ray film.
The Mann-Whitney U test was used as a statistical method using SPSS software version 17.0 (SPSS Inc, Chicago, IL, USA). A p-value < 0.05 was defined as statistically significant.
Cai, Y. et al. Vinpocetine suppresses pathological vascular remodeling by inhibiting vascular smooth muscle cell proliferation and migration. J Pharmacol Exp Ther 343, 479–488 (2012).
Rensen, S. S., Doevendans, P. A. & van Eys, G. J. Regulation and characteristics of vascular smooth muscle cell phenotypic diversity. Neth Heart J 15, 100–108 (2007).
Gomez, D. & Owens, G. K. Smooth muscle cell phenotypic switching in atherosclerosis. Cardiovasc Res 95, 156–164 (2012).
Tarkin, J. M., Joshi, F. R. & Rudd, J. H. PET imaging of inflammation in atherosclerosis. Nat Rev Cardiol 1038, 80 (2014).
Tatsumi, M., Cohade, C., Nakamoto, Y. & Wahl, R. L. Fluorodeoxyglucose uptake in the aortic wall at PET/CT: possible finding for active atherosclerosis. Radiology 229, 831–837 (2003).
Lederman, R. J. et al. Detection of atherosclerosis using a novel positron-sensitive probe and 18-fluorodeoxyglucose (FDG). Nucl Med Commun 22, 747–753 (2001).
Pyla, R., Poulose, N., Jun, J. Y. & Segar, L. Expression of conventional and novel glucose transporters, GLUT1, -9, -10, and -12, in vascular smooth muscle cells. Am J Physiol Cell Physiol 304, C574–C589 (2013).
Sheikine, Y. & Akram, K. FDG-PET imaging of atherosclerosis: do we know what we see? Atherosclerosis 211, 371–380 (2010).
Winkel, L. C., Hoogendoorn, A., Xing, R., Wentzel, J. J. & Van der Heiden, K. Animal models of surgically manipulated flow velocities to study shear stress-induced atherosclerosis. Atherosclerosis 241, 100–110 (2015).
Wei, S. et al. Apolipoprotein E-deficient rats develop atherosclerotic plaques in partially ligated carotid arteries. Atherosclerosis 243, 589–592 (2015).
Farb, A. et al. Extracellular matrix changes in stented human coronary arteries. Circulation 110, 940–947 (2004).
Satoh, K. et al. Cyclophilin A mediated vascular remodeling by promoting inflammation and vascular smooth muscle cell proliferation. Circulation 117, 3088–3098 (2008).
Newby, A. C. Matrix metalloproteinases regulate migration, proliferation, and death of vascular smooth muscle cells by degrading matrix and non-matrix substrates. Cardiovasc Res 69, 614–624 (2006).
Aikawa, M. et al. Human smooth muscle myosin heavy chain isoforms as molecular markers for vascular development and atherosclerosis. Circ Res 73, 1000–1012 (1993).
Owens, G. K., Kumar, M. S. & Wamhoff, B. R. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev 84, 767–801 (2004).
Xu, S. et al. Increased expression of Nox1 in neointimal smooth muscle cells promotes activation of matrix metalloproteinase-9. J Vasc Res 49, 242–248 (2012).
Ogawa, M., Nakamura, S., Saito, Y., Kosugi, M. & Magata, Y. What can be seen by 18F-FDG PET in atherosclerosis imaging? The effect of foam cell formation on 18F-FDG uptake to macrophage in vivo. J Nucl Med 53, 55–58 (2012).
Folco, E. J. et al. Hypoxia but not inflammation augments glucose uptake in human macrophages: Implications for imaging atherosclerosis with 18fluorine-labeled 2-deoxy-D-glucose positron emission tomography. J Am Coll Cardiol 58, 603–614 (2011).
Fogelstrand, P., Féral, C. C., Zargham, R. & Ginsberg, M. H. Dependence of proliferative vascular smooth muscle cells on CD98hc (4F2hc, SLC3A2). J Exp Med 206, 2397–2406 (2009).
Fog Bentzon, J., Otsuka, F., Virmani, R. & Falk, E. Mechanisms of plaque formation and rupture. Circ Res 114, 1852–1866 (2014).
Kim, E. J. et al. Novel PET imaging of atherosclerosis with 68Ga-labeled NOTA-Neomannosylated Human Serum Albumin. J Nucl Med 57, 1792–1797 (2016).
Wang, J. et al. Prevention of atherosclerosis by Yindan Xinnaotong capsule combined with swimming in rats. BMC Complement Altern Med 15, 109 (2015).
Rebsamen, M. C., Sun, J., Norman, A. W. & Liao, J. K. 1alpha,25-dihydroxyvitamin D3 induces vascular smooth muscle cell migration via activation of phosphatidylinositol 3-kinase. Circ Res 91, 17–24 (2002).
Loening, A. M. & Gambhir, S. S. Amide: a free software tool for multimodality medical image analysis. Mol Imaging 2, 131–137 (2003).
This study was supported by a grant from the Basic Science Research Program (#NRF-2015R1A2A01004202) through the National Research Foundation of Korea (NRF), which is funded by the Ministry of Science, ICT & Future Planning. This work was also supported by a grant from the Korea Health Technology R&D Project (#HI15C2796) of the Korea Health Industry Development Institute (KHIDI), which is funded by the Ministry of Health & Welfare, Republic of Korea.
The authors declare that they have no competing interests.
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
About this article
Cite this article
Pahk, K., Joung, C., Jung, SM. et al. Visualization of Synthetic Vascular Smooth Muscle Cells in Atherosclerotic Carotid Rat Arteries by F-18 FDG PET. Sci Rep 7, 6989 (2017). https://doi.org/10.1038/s41598-017-07073-3
Histochemistry and Cell Biology (2022)
Journal of Nuclear Cardiology (2021)
Disease-Relevant Single Cell Photonic Signatures Identify S100β Stem Cells and their Myogenic Progeny in Vascular Lesions
Stem Cell Reviews and Reports (2021)
A novel CD147 inhibitor, SP-8356, reduces neointimal hyperplasia and arterial stiffness in a rat model of partial carotid artery ligation
Journal of Translational Medicine (2019)